ACP says wait until 50. Should average-risk women start at 40?

Here is the practical takeaway: as of April 30, 2026, average-risk women in the United States are hearing two different messages about when routine mammograms should begin. The American College of Physicians now says routine every-two-year screening should start at age 50 for asymptomatic, average-risk women. But the current U.S. Preventive Services Task Force recommendation still says average-risk women should get a mammogram every two years from ages 40 to 74.

That means women in their 40s should not assume screening has suddenly been “moved back” nationwide. ACP issued a professional guidance update on April 17, 2026. It did not replace the current federal task force recommendation, and CDC public screening guidance still reflects screening beginning at 40 for average-risk patients. HealthCare.gov also continues to describe preventive-care coverage rules that generally depend on plan type and in-network care.

What changed on April 17, 2026

ACP’s new guidance statement, published in Annals of Internal Medicine, says asymptomatic, average-risk women ages 50 to 74 should have mammography every two years. For women ages 40 to 49, ACP says the decision should be individualized after a discussion about personal risk, values, and the possible benefits and harms of screening.

ACP also says women age 75 and older, or women with limited life expectancy, should discuss whether to stop routine screening. For average-risk women with dense breasts, ACP says clinicians can consider supplemental digital breast tomosynthesis, often called 3D mammography, but it advises against supplemental MRI or ultrasound for average-risk women in that group.

This is an updated guidance statement, not a new randomized trial and not a federal rule. In other words, it reflects ACP’s reading of existing evidence and guidelines, not a sudden new discovery that settles the debate.

The key reality check: federal guidance still starts at 40

The current USPSTF recommendation still says women ages 40 to 74 at average risk should get screening mammography every two years. The CDC’s breast cancer screening page still reflects that advice for average-risk women.

That is why the ACP update is confusing to many patients: one major physician group now says routine screening can wait until 50, while the federal task force still says 40 to 74. Both groups support biennial screening once it starts. The main disagreement is when routine screening should begin for average-risk women in their 40s.

The USPSTF also says its recommendation applies not only to cisgender women but to all people assigned female at birth who are age 40 or older and at average risk. That is worth knowing because many public-facing screening pages use the word “women,” while the task force language is broader.

Why the advice conflicts

ACP and USPSTF are weighing the same long-running tradeoff differently.

ACP emphasizes that, for average-risk women ages 40 to 49, the benefits are less certain and the harms may matter more. Those harms can include false-positive results, extra imaging, biopsies, anxiety, overdiagnosis, overtreatment, and some radiation exposure.

USPSTF reaches a different bottom line. It says biennial screening from ages 40 to 74 has a moderate net benefit overall. Its recommendation also notes that current evidence does not show the same level of benefit for every age group, but the task force still concludes there is enough overall benefit to recommend starting at 40 rather than waiting until 50.

So this is not a case of one group saying mammograms work and another saying they do not. The disagreement is about balance: how much benefit earlier screening adds for women in their 40s, and how much weight to give the downsides of finding problems that may never have caused illness.

Who this article is about, and who it is not about

This article is about people at average risk who do not have breast symptoms.

ACP says its “average-risk” guidance does not cover people with a personal history of breast cancer, a prior high-risk breast lesion, a known mutation such as BRCA1 or BRCA2, another familial breast cancer risk syndrome, or a history of high-dose chest radiation at a young age.

The USPSTF recommendation also excludes people with certain clearly high-risk situations, including BRCA-related syndromes, prior breast cancer, high-risk lesions, or prior high-dose chest radiation. But USPSTF says its recommendation still applies to many people who have dense breasts or a family history of breast cancer.

If you have a strong family history, dense breasts, a prior abnormal biopsy, or you were told your risk is elevated for another reason, it is reasonable to ask your clinician whether you still fit into the simple “average-risk” bucket. That question matters because higher-risk patients often need a more individualized plan.

What dense breasts do and do not change

Dense breasts can make screening more complicated. They are common, and they can both raise breast cancer risk and make cancers harder to see on a standard mammogram.

ACP says clinicians may consider supplemental digital breast tomosynthesis for average-risk women with dense breasts. USPSTF, however, says there is still not enough evidence to recommend for or against supplemental MRI or ultrasound after an otherwise negative screening mammogram in women with dense breasts.

That does not mean extra imaging never helps. It means the evidence is still not strong enough for the federal task force to make a blanket recommendation for everyone with dense breasts. If you were newly told you have dense breasts, the practical next step is not to panic. It is to ask what kind of mammography you had, whether 3D mammography is available, and whether your overall risk profile changes the screening discussion.

What about insurance and cost?

For now, federal patient-facing sources still describe screening mammography beginning at age 40 within the preventive-services framework. The CDC says most health insurance plans are required to cover screening mammograms every one to two years for women beginning at age 40 without out-of-pocket costs. HealthCare.gov also says most health plans must cover a set of preventive screening services at no cost to the patient.

But there is an important catch: HealthCare.gov says that in general, those no-cost rules apply when care is delivered by an in-network provider, and coverage can vary by plan and circumstance. A zero-dollar bill is not guaranteed in every situation.

In plain English, the ACP update does not automatically mean your mammogram at 40 will no longer be covered. Still, plan details, state rules, employer coverage, provider network status, and whether the visit is billed as screening or diagnostic care can all affect the final bill. If cost is a concern, ask your insurer and the imaging center to confirm that the test is being scheduled and billed as preventive screening and that the facility is in network.

If you are 40 to 49, what should you ask now?

If you are in your 40s and average risk, this is a good short list to bring to a primary care or gynecology visit:

Am I truly average risk, or do my family history or past results change that?
How do you weigh the benefits and harms of starting screening now instead of waiting until 50 for someone like me?
Would biennial screening make sense for me now, or is there a reason to discuss a different schedule?
If I have dense breasts, is 3D mammography available where I go?
Will this be covered as preventive screening under my plan, and is the facility in network?

If you are overdue for screening, the conflicting headlines are not a reason to disappear from care. A reasonable next step is to review your own risk with a clinician and make a plan based on the guideline your care team follows and your health priorities.

This is about screening, not symptoms

Routine screening is for people without symptoms. If you notice a new breast lump, swelling or thickening, skin dimpling, redness or flaky skin around the nipple, nipple pulling, bloody or other unusual nipple discharge, a change in breast size or shape, or pain in one area of the breast, do not wait for your next routine mammogram.

The CDC says these symptoms can happen with conditions other than cancer, but they still need prompt medical attention. Call a clinician promptly if you notice new breast changes, even if you recently had a normal mammogram. If you are also feeling acutely ill or have rapidly worsening symptoms, use urgent or emergency care.

Bottom line

The ACP update did not make the federal age-40 recommendation disappear. It added another influential voice to an already unsettled screening debate.

As of April 30, 2026, average-risk women in the United States are still looking at two credible but conflicting starting ages: ACP says routine biennial mammograms should start at 50, while USPSTF and CDC public guidance still support screening every two years from 40 to 74. If you are in your 40s, the safest next move is not to guess from a headline. It is to ask where you fall on the risk spectrum, which guideline your clinician is using, and how that fits with your values, insurance coverage, and tolerance for the tradeoffs that come with screening.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.